Dr Susie Bae
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
66 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
CAPTURE: A phase II trial evaluating alpelisib fulvestrant vs capecitabine in advanced breast cancer patients with PIK3CA-mutant circulating DNA following CDK4/6 inhibition.
DOI: 10.1200/JCO.2026.44.16_suppl.10642026
Journal article
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
DOI: 10.1016/j.ejca.2026.1166662026
Journal article
Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners – an international observational cohort study
DOI: 10.1136/bmjopen-2025-1144222026
Journal article
178P Treatment patterns and outcomes for patients with abdominal, pelvic and retroperitoneal leiomyosarcoma and liposarcoma: an Australian sarcoma centre experience
DOI: 10.1016/j.esmorc.2026.1003842026
Journal article
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
DOI: 10.1016/j.esmoop.2025.1060442026
Journal article
Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic retroperitoneal sarcoma working group (TARPSWG)
DOI: 10.1016/j.ctrv.2025.1030862026
Journal article
The value of a second expert opinion in histopathological diagnosis of bone and soft tissue sarcoma: a systematic review
DOI: 10.1016/j.pathol.2025.09.005
RECENT SCHOLARLY WORKS
2026
Journal article
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory
DOI: 10.1007/s40291-025-00820-72025
Conference Proceedings
2742P Real-world experience of sorafenib (SFN) in desmoid tumours (DT): A single-centre Australian study
DOI: 10.1016/j.annonc.2025.08.33522025
Conference Proceedings
2725P Real-world experience of cabozantinib monotherapy in relapsed or refractory osteosarcoma and Ewing Sarcoma: A single-centre Australian study
DOI: 10.1016/j.annonc.2025.08.3335